Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference42 articles.
1. Bannister CA, Holden SE (2014) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 16:1165–1173
2. Baxter CA, Das R, Langerman H, Mills EJ, Druyts E, Siliman G, Balijepalli C, Thorlund K (2015) ncreased risk of cardiovascular-related events associated with sulfonyureas compared to other antihyperglycaemic drugs : a Bayesian metaanalysis of survival data. Diabetologia 58(Suppl.1):64
3. Burke MA, Mutharasan RK (2008) The sulfonylurea receptor, an atypicalATP-binding cassette protein, and its regulation of the KATP channel. Circ Res 102:164–176
4. Corrao G, Romio SA (2011) Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a populationbased cohort study in Italy. Eur J Clin Pharmacol 67:289–299
5. Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL (2013) Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab 98:668–677
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献